These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2788548

  • 1. Oxalate retention in chronic renal failure: tubular vs glomerular diseases.
    Tomson CR, Channon SM, Ward MK, Laker MF.
    Clin Nephrol; 1989 Aug; 32(2):87-95. PubMed ID: 2788548
    [Abstract] [Full Text] [Related]

  • 2. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
    Tomson CR, Channon SM, Ward MK, Laker MF.
    Nephrol Dial Transplant; 1989 Aug; 4(9):792-9. PubMed ID: 2516611
    [Abstract] [Full Text] [Related]

  • 3. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB, Johnsen LF, Woldseth B, Morkrid L, Hartmann A.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A, Fujii M, Shirai D, Mikami H, Okada A, Imai E, Ando A, Orita Y, Kamada T.
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [Abstract] [Full Text] [Related]

  • 5. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB, Draibe SA, Feiten SF, Chiarello PG, Vannucchi H, Cuppari L.
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma oxalate concentration in chronic renal disease.
    Boer P, van Leersum L, Hené RJ, Mees EJ.
    Am J Kidney Dis; 1984 Sep; 4(2):118-22. PubMed ID: 6383028
    [Abstract] [Full Text] [Related]

  • 12. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP, Rose GA.
    Clin Chim Acta; 1986 Jan 15; 154(1):49-58. PubMed ID: 3943224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
    Caravaca F, Ruiz AB, Escola JM, Hernández Gallego R, Cerezo I, Fernández N, Barroso S, Martín MV.
    Nefrologia; 2007 Jan 15; 27(4):466-71. PubMed ID: 17944584
    [Abstract] [Full Text] [Related]

  • 16. [Demography and effects of chronic renal insufficiency in Ile-de-France].
    Jungers P, Giraud E, Chauveau P, Geffriaud-Ricouard C, Man NK, Altman JJ, Jacobs C, Grünfeld JP.
    Nephrologie; 1996 Jan 15; 17(8):429-34. PubMed ID: 9036365
    [Abstract] [Full Text] [Related]

  • 17. [Epidemiology of severe chronic renal insufficiency in Burkina Faso].
    Lengani A, Coulibaly G, Laville M, Zech P.
    Sante; 1997 Jan 15; 7(6):379-83. PubMed ID: 9503495
    [Abstract] [Full Text] [Related]

  • 18. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Jan 15; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of protein load on kidney functions in patients with chronic glomerulonephritis].
    Esaian AM, Kucher AG, Kaiukov IG, Ermakov IuA, Nikogosian IuA, Riabov SI.
    Ter Arkh; 2002 Jan 15; 74(6):19-24. PubMed ID: 12136476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.